Want to see HK:1255 full AI Analyst Report?
Total Valuation
TATA Health International Holdings Ltd. has a market cap or net worth of HK$444.41M. The enterprise value is HK$871.12M.
Market CapHK$444.41M
Enterprise ValueHK$871.12M
Share Statistics
TATA Health International Holdings Ltd. has 242,845,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding242,845,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
TATA Health International Holdings Ltd.’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is 80.15%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)80.15%
Return on Capital Employed (ROCE)0.46
Revenue Per Employee932.70K
Profits Per Employee124.77K
Employee Count107
Asset Turnover1.10
Inventory Turnover2.05
Valuation Ratios
The current PE Ratio of TATA Health International Holdings Ltd. is ―. TATA Health International Holdings Ltd.’s PEG ratio is -0.20.
PE Ratio―
PS Ratio3.16
PB Ratio-5.80
Price to FCF-14.09
Price to Operating Cash Flow-21.28
PEG Ratio-0.20
Income Statement
In the last 12 months, TATA Health International Holdings Ltd. had revenue of 99.80M and earned 13.35M in profits. Earnings per share was 0.06.
Revenue99.80M
Gross Profit80.26M
Operating Income-23.19M
Pretax Income13.99M
Net Income13.35M
EBITDA-11.64M
Earnings Per Share (EPS)0.06
Cash Flow
In the last 12 months, operating cash flow was -20.88M and capital expenditures -5.54M, giving a free cash flow of -26.43M billion.
Operating Cash Flow-20.88M
Free Cash Flow-26.43M
Free Cash Flow per Share-0.11
Dividends & Yields
TATA Health International Holdings Ltd. pays an annual dividend of HK$0.023, resulting in a dividend yield of 4.34%
Dividend Per ShareHK$0.023
Dividend Yield4.34%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.36
52-Week Price Change510.00%
50-Day Moving Average2.09
200-Day Moving Average2.02
Relative Strength Index (RSI)26.64
Average Volume (3m)9.40K
Important Dates
TATA Health International Holdings Ltd. upcoming earnings date is Apr 1, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateApr 1, 2027
Ex-Dividend Date―
Financial Position
TATA Health International Holdings Ltd. as a current ratio of 0.50, with Debt / Equity ratio of -59.32%
Current Ratio0.50
Quick Ratio0.43
Debt to Market Cap0.03
Net Debt to EBITDA-0.68
Interest Coverage Ratio-8.29
Taxes
In the past 12 months, TATA Health International Holdings Ltd. has paid 637.00K in taxes.
Income Tax637.00K
Effective Tax Rate0.05
Enterprise Valuation
TATA Health International Holdings Ltd. EV to EBITDA ratio is -27.80, with an EV/FCF ratio of -14.45.
EV to Sales3.24
EV to EBITDA-27.80
EV to Free Cash Flow-14.45
EV to Operating Cash Flow-17.41
Balance Sheet
TATA Health International Holdings Ltd. has HK$10.43M in cash and marketable securities with HK$32.63M in debt, giving a net cash position of -HK$22.20M billion.
Cash & Marketable SecuritiesHK$10.43M
Total DebtHK$32.63M
Net Cash-HK$22.20M
Net Cash Per Share-HK$0.09
Tangible Book Value Per Share-HK$0.22
Margins
Gross margin is 72.79%, with operating margin of -23.24%, and net profit margin of 13.38%.
Gross Margin72.79%
Operating Margin-23.24%
Pretax Margin14.02%
Net Profit Margin13.38%
EBITDA Margin-11.67%
EBIT Margin-23.24%
Analyst Forecast
The average price target for TATA Health International Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.34%
EPS Growth Forecast82.34%